Advertisement

European Journal of Pediatrics

, Volume 166, Issue 5, pp 433–441 | Cite as

Medication use during pregnancy and the risk of childhood cancer in the offspring

  • Joachim Schüz
  • Thomas Weihkopf
  • Peter KaatschEmail author
Original Paper

Abstract

The young age at onset of many cancers in childhood has led to investigations on maternal exposures during pregnancy. Data from a population-based case-control study in Germany (1992–1997) that included 1,867 cases and 2,057 controls was used to investigate this question. Maternal use of vitamin, folate or iron supplementation was associated with a reduced risk of non-Hodgkin lymphoma and tumors and, less clearly, with leukemia, but not with CNS tumors. An increased risk of neuroblastoma was associated most markedly with diuretics and other antihypertensives, but also with vitamin, folate or iron supplementation. No associations were seen with pain relievers, antinauseants or cold medications, nor with delivery by Caesarian section. The strengths of this study are its population base, the large number of cases and the inclusion of different case groups to identify disease specificity of associations. The limitation of this study is an exposure assessment relying on maternal self-reports. In conclusion, these data indicate a potential influence of some maternal medication during pregnancy on the risk of childhood cancer in the offspring; however, no clear picture is seen.

Keywords

Child Leukemia Neoplasms Pregnancy Medication 

Abbreviations

ALL

acute lymphoblastic leukemia

AML

acute myeloblastic leukemia

CNS

central nervous system

NHL

non-Hodgkin lymphoma

OR

odds ratio

CI

confidence interval

SES

socioeconomic status

Notes

Acknowledgements

We would especially like to thank Dr. Ina Reiß for her skillful work on the data set and for the preparation of preliminary analyses. We would like to thank Monika Decher-Neff and Ilona Kerenyi for their assistance in coding the medications. We would also like to thank Drs. Rolf Meinert, Uwe Kaletsch and Jörg Michaelis for their work during the conducting of the original study.

References

  1. 1.
    Anderson LM, Diwan BA, Fear NT, Roman E (2000) Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 108:573–594PubMedCrossRefGoogle Scholar
  2. 2.
    Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Munlinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A (1999) Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485–1490PubMedCrossRefGoogle Scholar
  3. 3.
    Bonati M, Bortelus R, Marchetti F, Romero M, Rognoni G (1990) Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 38:325–328PubMedCrossRefGoogle Scholar
  4. 4.
    Brookmeyer R, Liang KY, Linet M (1986) Matched case-control designs and overmatched analyses. Am J Epidemiol 124:693–701PubMedGoogle Scholar
  5. 5.
    Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT (1993) Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 329:536–541PubMedCrossRefGoogle Scholar
  6. 6.
    Bunin GR, Buckley JD, Boesel CP, Rorke LB, Meadows AT (1994) Risk factors for astrocytic glioma and primitive neuroectodermal tumor of the brain in young children: a report from the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev 3:197–204PubMedGoogle Scholar
  7. 7.
    Carozza SE, Olshan AF, Faustman EM, Gula MJ, Kolonel LN, Austin DF, West ED, Weiss NS, Swanson GM, Lyon LK, Hedley-Whyte T, Gilles FH, Aschenbrenner C, Leviton A (1995) Maternal exposure to N-nitrosatable drugs as a risk factor for childhood brain tumours. Int J Epidemiol 24:308–312PubMedCrossRefGoogle Scholar
  8. 8.
    Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, Bondy ML, Pollock BH (2004) Maternal medication use and neuroblastoma in offspring. Am J Epidemiol 159:721–731PubMedCrossRefGoogle Scholar
  9. 9.
    Feuring M, Melchert F, Wehling M (1999) Pharmacotherapy for hypertonia in pregnancy. Gynäkologe 32:443–449Google Scholar
  10. 10.
    Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB (1997) Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94:13950–13954PubMedCrossRefGoogle Scholar
  11. 11.
    German Childhood Cancer Registry: Annual Report 2004 (1980–2003) Technical report, Institute of Medical Biostatistics, Epidemiology and Informatics, 2005 (http://www.kinderkrebsregister.de)
  12. 12.
    Greaves MF (2002) Childhood leukaemia. BMJ 324:283–287PubMedCrossRefGoogle Scholar
  13. 13.
    Hjalgrim LL, Madsen HO, Melbye M, Jorgensen P, Christiansen M, Andersen P, Pallisgaat N, Hokland P, Clausen N, Ryder LP, Schmiegelow K, Hjalgrim H (2002) Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer 87:994–999PubMedCrossRefGoogle Scholar
  14. 14.
    Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S (2004) Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control 15:559–570PubMedCrossRefGoogle Scholar
  15. 15.
    Khera KS (1987) Maternal toxicity of drugs and metabolic disorders-a possible etiologic factor in the intrauterine death and congenital malformation: a critique on human data. Crit Rev Toxicol 17:345–375PubMedGoogle Scholar
  16. 16.
    Kim YI (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66–68PubMedCrossRefGoogle Scholar
  17. 17.
    Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823PubMedCrossRefGoogle Scholar
  18. 18.
    Kramer S, Ward E, Meadows AT, Malone KE (1987) Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst 78:797–804PubMedGoogle Scholar
  19. 19.
    Law GR, Smith AG, Roman E; United Kingdom Childhood Cancer Study Investigators (2002) The importance of full participation: lessons from a national case-control study. Br J Cancer 86:350–355PubMedCrossRefGoogle Scholar
  20. 20.
    Lightfoot TJ, Roman E (2004) Causes of childhood leukaemia and lymphoma. Toxicol Appl Pharmacol 199:104–117PubMedCrossRefGoogle Scholar
  21. 21.
    Little J (1999) Epidemiology of childhood cancer. IARC Scientific Publications No 149. Lyon, FranceGoogle Scholar
  22. 22.
    Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC (1996) Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 143:996–1001PubMedGoogle Scholar
  23. 23.
    Michaelis J, Haaf HG, Zöllner J, Kaatsch P, Krummenauer F, Berthold F (1996) Case-control study of neuroblastoma in West Germany after the Chernobyl accident. Klin Padiatr 208:172–178PubMedCrossRefGoogle Scholar
  24. 24.
    Neuhäuser M, Becher H (1997) Improved odds ratio estimation by post hoc stratification of case-control data. Stat Med 16:993–1004PubMedCrossRefGoogle Scholar
  25. 25.
    Olshan AF, Faustman EM (1989) Nitrosable drug exposure during pregnancy and adverse outcome. Int J Epidemiol 18:891–899PubMedCrossRefGoogle Scholar
  26. 26.
    Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH (2002) Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology 13:575–580PubMedCrossRefGoogle Scholar
  27. 27.
    Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, Kalmanti M, Kouliouskas D, Kosmidis H, Panagiotou JP, Piperopoulou F, Tzortzatou F (1997) The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 76:1241–1247PubMedGoogle Scholar
  28. 28.
    Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL (1996) Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 5:599–605PubMedGoogle Scholar
  29. 29.
    Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Modan B, Holly EA, Fillippini G, Cordier S, Peris-Bonet R, Choi W, Little J, Arslan A (1998) Results from an international case-control study of childhood brain tumors: the role of prenatal vitamin supplementation. Environ Health Perspect 106:887–892PubMedCrossRefGoogle Scholar
  30. 30.
    Rath W (1999) Hypertensive diseases in pregnancy. Gynäkologe 32:432–442Google Scholar
  31. 31.
    Robison LL, Buckley JD, Bunin G (1995) Assessment of environmental and genetic factors in the biology of childhood cancers: the Children‘s Cancer Group epidemiology program. Environ Health Perspect 6:111–116CrossRefGoogle Scholar
  32. 32.
    Roman E, Ansell P, Bull D (1997) Leukaemia and non-Hodgkin’s lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease? Br J Cancer 76:406–415PubMedGoogle Scholar
  33. 33.
    Roman E, Simpson J, Ansell P, Lightfoot T, Mitchell C, Eden TO (2005) Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. Eur J Cancer 41:749–759PubMedCrossRefGoogle Scholar
  34. 34.
    Ross JA, Swensen AR (2000) Prenatal epidemiology of pediatric tumors. Curr Oncol Rep 2:234–241PubMedGoogle Scholar
  35. 35.
    Schüz J, Kaatsch P (2002) Epidemiology of pediatric tumors of the central nervous system. Exp Rev Neurotherapeutics 2:469–480CrossRefGoogle Scholar
  36. 36.
    Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639PubMedCrossRefGoogle Scholar
  37. 37.
    Schüz J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J (2001) Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol 54:702–709PubMedCrossRefGoogle Scholar
  38. 38.
    Schüz J, Spector LF, Ross JA (2003) Bias in studies of parental self-reported occupational exposures and childhood cancer. Am J Epidemiol 158:710–716PubMedCrossRefGoogle Scholar
  39. 39.
    Schwartzbaum JA (1992) Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol 135:1358–1367PubMedGoogle Scholar
  40. 40.
    Shaw AK, Infante-Rivard C, Morrison HI (2004) Use of medication during pregnancy and risk of childhood leukemia (Canada). Cancer Causes Control 15:931–937PubMedCrossRefGoogle Scholar
  41. 41.
    Shu XO, Perentesis JP, Wen W, Buckley JD, Boyle E, Ross JA, Robison LL (2004) Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev 13:1230–1235PubMedGoogle Scholar
  42. 42.
    Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181–192PubMedCrossRefGoogle Scholar
  43. 43.
    Stokes ME, Davis CS, Koch GG (1995) Categorical data analysis using the SAS System. SAS Institute Inc., Cary, NC, USAGoogle Scholar
  44. 44.
    Thompson JR, Gerald PF, Willoughby ML, Armstrong BK (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358:1935–1940PubMedCrossRefGoogle Scholar
  45. 45.
    UK Childhood Cancer Study Investigators (2000). The United Kingdom Childhood Cancer Study: objectives, materials and methods. UK Childhood Cancer Study Investigators. Br J Cancer 82:1073–1102CrossRefGoogle Scholar
  46. 46.
    Unadkat JD, Dahlin A, Vijay S (2004) Placental drug transporters. Curr Drug Metab 5:125–131PubMedCrossRefGoogle Scholar
  47. 47.
    van Poppel G, van den Berg H (1997) Vitamins and cancer. Cancer Lett 114:195–202PubMedCrossRefGoogle Scholar
  48. 48.
    Wen W, Shu XO, Potter JD, Severson RK, Buckley JD, Reaman GH, Robison LL (2002) Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 95:1786–1794PubMedCrossRefGoogle Scholar
  49. 49.
    Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, Saha V, Biondi A, Greaves MF (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354:1499–1503PubMedCrossRefGoogle Scholar
  50. 50.
    Wogelius P, Poulsen S, Sorensen HT (2005) Validity of parental-reported questionnaire data on Danish children's use of asthma-drugs: a comparison with a population-based prescription database. Eur J Epidemiol 20:17–22PubMedCrossRefGoogle Scholar
  51. 51.
    Yankowitz J (2004) Pharmacologic treatment of hypertensive disorders during pregnancy. J Perinat Neonat Nurs 18:230–240Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Joachim Schüz
    • 1
    • 2
  • Thomas Weihkopf
    • 1
  • Peter Kaatsch
    • 1
    Email author
  1. 1.Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI)Johannes Gutenberg-University of MainzMainzGermany
  2. 2.Institute of Cancer EpidemiologyDanish Cancer SocietyCopenhagenDenmark

Personalised recommendations